# Council Regulation (EC) No 129/2007 of 12 February 2007 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87, Annex IV: List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006

Extent: E+W+S+N.I.

ID No
CN code
CAS RN
Name
677
2918 90 90
157283-68-6
isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl]hept-5-enoate
travoprost (INN)
603
2924 29 95
112522-64-2
4-acetamido-2'-aminobenzanilide
tacedinaline (INN)
69
2924 29 95
166518-60-1
N-[(2,6-diisopropylphenoxy)sulfonyl]-2-(2,4,6-triisopropylphenyl)acetamide
avasimibe (INN)
441
2928 00 90
53016-31-2
13-ethyl-17-alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime
norelgestromin (INN)
833
2930 90 30
583-91-5
2-hydroxy-4-(methylthio)butyric acid
desmeninol (INN)
273
2932 99 70
114870-03-0
methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-beta-D-glucopyranuronosyl-(1,4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1,4)-2-deoxy-2-(sulfoamino)-6-(hydrogen sulfate)-alpha-D-glucopyranoside, decasodium salt
fondaparinux sodium (INN)
627
2933 39 99
75970-99-9
[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl](4-piperidyl)amine
tecastemizole (INN)
159
2933 39 99
100643-71-8
8-chloro-11-(4-piperidylidene)-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine
desloratadine (INN)
549
2933 39 99
168273-06-1
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidino-1H-pyrazole-3-carboxamide
rimonabant (INN)
380
2933 39 99
193275-84-2
4-{4-[(11R)-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidinocarbonylmethyl}piperidine-1-carboxamide
lonafarnib (INN)
397
2933 49 90
146362-70-1
2-{[1-(7-chloro-4-quinolyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonylamino}adamantane-2-carboxylic acid
meclinertant (INN)
641
2933 59 95
147127-20-6
(R)-[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphosphonic acid
tenofovir (INN)
205
2933 59 95
149950-60-7
6-benzyl-1-(ethoxymethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione
emivirine (INN)
511
2933 59 95
153537-73-6
(S)-2-(4-{[(2,7-dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-ynyl)amino}-2-fluorobenzamido)-4-(1H-tetrazol-5-yl)butyric acid
plevitrexed (INN)
686
2934 99 90
112984-60-8
(+-)-6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
ulifloxacin (INN)
33
2934 99 90
145514-04-1
(2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-ylmethanol
amdoxovir (INN)
513
2934 99 90
171228-49-2
4-[4-(4-{4-[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-ylmethyloxy]phenyl}piperazin-1-yl)phenyl]-1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,2,4-triazol-5(4H)-one
posaconazole (INN)
293
2934 99 90
184475-35-2
(3-chloro-4-fluorophenyl)[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine
gefitinib (INN)
539
2935 00 90
150375-75-0
N'-{(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-ylcarbonyl}-L-prolinamide
relcovaptan (INN)
39
2935 00 90
161814-49-9
(3S)-tetrahydrofuran-3-yl (1S,2R)-3-[(4-aminophenylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate
amprenavir (INN)
115
2935 00 90
169590-42-5
4-[5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
celecoxib (INN)
654
2935 00 90
180200-68-4
4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide
tilmacoxib (INN)
690
2935 00 90
181695-72-7
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
valdecoxib (INN)
520
2935 00 90
192329-42-3
(S)-N-hydroxy-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxamide
prinomastat (INN)
364
3002 10 95
193700-51-5
SC-70935
leridistim (INN)

---
Source: https://www.legislation.gov.uk/eur/2007/129/annex/IV (the official version)
Page: https://openlegislation.uk/eu-regulation-2007-129/annex-IV
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.